NASDAQ:ANIK

Anika Therapeutics SEC Filings & 10K Form

$40.05
-0.81 (-1.98 %)
(As of 08/4/2021 12:00 AM ET)
Add
Compare
Today's Range
$39.90
$41.15
50-Day Range
$39.99
$46.89
52-Week Range
$32.04
$48.37
Volume33,340 shs
Average Volume118,667 shs
Market Capitalization$576.36 million
P/E RatioN/A
Dividend YieldN/A
Beta1.23

Anika Therapeutics (NASDAQ:ANIK) SEC Filings

DateFilerForm TypeView
06/21/2021
3:20 PM
Anika Therapeutics (Issuer)
VOGT SUSAN L N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2021
3:19 PM
Anika Therapeutics (Issuer)
Thompson Jeffery S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2021
3:18 PM
Anika Therapeutics (Issuer)
Richard Stephen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2021
3:17 PM
Anika Therapeutics (Issuer)
Larsen Glenn R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2021
3:16 PM
Anika Therapeutics (Issuer)
LAND RAYMOND J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2021
3:31 PM
Anika Therapeutics (Issuer)
Blanchard Cheryl R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2021
3:11 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2021
3:30 PM
Anika Therapeutics (Filer)
Form DEFA14A
04/26/2021
3:57 PM
Anika Therapeutics (Filer)
Form 10-K/A
03/11/2021
4:14 PM
Anika Therapeutics (Issuer)
Loerop James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2021
4:12 PM
Anika Therapeutics (Issuer)
Levitz Michael L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2021
4:10 PM
Anika Therapeutics (Issuer)
Finnerty Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2021
4:09 PM
Anika Therapeutics (Issuer)
Colleran David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2021
4:08 PM
Anika Therapeutics (Issuer)
Blanchard Cheryl R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2021
4:06 PM
Anika Therapeutics (Issuer)
Colleran David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2021
4:18 PM
Anika Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/01/2021
4:19 PM
Anika Therapeutics (Issuer)
Loerop James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2021
8:45 AM
AMERIPRISE FINANCIAL INC (Filed by)
Anika Therapeutics (Subject)
Form SC 13G
02/10/2021
8:48 AM
Anika Therapeutics (Subject)
RENAISSANCE TECHNOLOGIES LLC (Filed by)
Form SC 13G
02/05/2021
10:08 AM
Anika Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
01/25/2021
3:56 PM
Anika Therapeutics (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
11/12/2020
3:08 PM
Anika Therapeutics (Issuer)
LAND RAYMOND J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2020
3:11 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2020
3:14 PM
Anika Therapeutics (Issuer)
Finnerty Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2020
3:10 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/08/2020
5:14 PM
Anika Therapeutics (Issuer)
Anika Therapeutics (Issuer)
Richard Stephen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/08/2020
5:12 PM
Anika Therapeutics (Issuer)
Anika Therapeutics (Issuer)
HENNEMAN JOHN B III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/08/2020
5:04 PM
Anika Therapeutics (Issuer)
Richard Stephen (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/08/2020
5:03 PM
Anika Therapeutics (Issuer)
HENNEMAN JOHN B III (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/08/2020
4:22 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/17/2020
2:25 PM
Anika Therapeutics (Subject)
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (Filed by)
Form SC 13G/A
08/12/2020
3:10 PM
Anika Therapeutics (Issuer)
Levitz Michael L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
8:30 AM
Anika Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2020
3:05 PM
Anika Therapeutics (Filer)
Form 10-Q/A
08/05/2020
4:04 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2020
5:50 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2020
3:06 PM
Anika Therapeutics (Issuer)
Loerop James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2020
5:41 PM
Anika Therapeutics (Issuer)
Blanchard Cheryl R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2020
3:05 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2020
3:05 PM
Anika Therapeutics (Issuer)
Colleran David (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/05/2020
8:22 PM
Anika Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/02/2020
3:05 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2020
5:54 PM
Anika Therapeutics (Issuer)
LAND RAYMOND J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2020
5:53 PM
Anika Therapeutics (Issuer)
Finnerty Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2020
5:53 PM
Anika Therapeutics (Issuer)
Loerop James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2020
5:52 PM
Anika Therapeutics (Issuer)
VOGT SUSAN L N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2020
5:51 PM
Anika Therapeutics (Issuer)
Larsen Glenn R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2020
5:50 PM
Anika Therapeutics (Issuer)
Bower Joseph L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2020
5:49 PM
Anika Therapeutics (Issuer)
Cheung Sylvia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2020
5:48 PM
Anika Therapeutics (Issuer)
Blanchard Cheryl R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2020
5:47 PM
Anika Therapeutics (Issuer)
Thompson Jeffery S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2020
11:56 AM
Anika Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
02/06/2020
4:12 PM
Anika Therapeutics (Issuer)
Cheung Sylvia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2020
3:05 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2020
3:05 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/29/2019
3:06 PM
Anika Therapeutics (Issuer)
Bower Joseph L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2019
4:40 PM
Anika Therapeutics (Issuer)
Cheung Sylvia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2019
4:20 PM
Anika Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/30/2019
3:05 PM
Anika Therapeutics (Issuer)
Larsen Glenn R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2019
3:05 PM
Anika Therapeutics (Issuer)
Bower Joseph L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2019
3:06 PM
Anika Therapeutics (Issuer)
Thompson Jeffery S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2019
3:06 PM
Anika Therapeutics (Issuer)
LAND RAYMOND J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2019
3:05 PM
Anika Therapeutics (Issuer)
Darling Joseph G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2019
4:00 PM
Anika Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/24/2019
3:06 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2019
3:05 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2019
3:10 PM
Anika Therapeutics (Issuer)
Loerop James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2019
3:05 PM
Anika Therapeutics (Issuer)
Loerop James (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/26/2019
3:05 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2019
3:10 PM
Anika Therapeutics (Filer)
Form DEFA14A
04/25/2019
3:05 PM
Anika Therapeutics (Filer)
Form DEF 14A
04/12/2019
3:05 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2019
3:05 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2019
7:30 AM
Anika Therapeutics (Issuer)
Darling Joseph G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
3:36 PM
Anika Therapeutics (Issuer)
VOGT SUSAN L N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
3:36 PM
Anika Therapeutics (Issuer)
Thompson Jeffery S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
3:34 PM
Anika Therapeutics (Issuer)
Hague Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
3:33 PM
Anika Therapeutics (Issuer)
Finnerty Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
3:32 PM
Anika Therapeutics (Issuer)
Darling Joseph G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
3:32 PM
Anika Therapeutics (Issuer)
Cheung Sylvia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
3:31 PM
Anika Therapeutics (Issuer)
BOWER JOSEPH I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
3:31 PM
Anika Therapeutics (Issuer)
Blanchard Cheryl R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
3:30 PM
Ahn Edward S. (Reporting)
Anika Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2019
3:05 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2019
7:38 AM
Anika Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/08/2019
7:52 AM
Anika Therapeutics (Subject)
DIMENSIONAL FUND ADVISORS LP (Filed by)
Form SC 13G/A
02/06/2019
8:15 AM
Anika Therapeutics (Issuer)
Cheung Sylvia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2019
8:15 AM
Ahn Edward S. (Reporting)
Anika Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2019
7:38 AM
Anika Therapeutics (Issuer)
Hague Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2018
3:30 PM
Anika Therapeutics (Subject)
Form SC 13G/A
10/30/2018
3:05 PM
Anika Therapeutics (Issuer)
Hague Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/26/2018
3:21 PM
Anika Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/25/2018
3:10 PM
Anika Therapeutics (Issuer)
VOGT SUSAN L N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/25/2018
3:05 PM
Anika Therapeutics (Issuer)
VOGT SUSAN L N (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/24/2018
3:06 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2018
7:30 AM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2018
3:15 PM
Anika Therapeutics (Issuer)
Blanchard Cheryl R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2018
3:10 PM
Anika Therapeutics (Issuer)
Blanchard Cheryl R (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/05/2018
3:05 PM
Anika Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2018
4:28 PM
Anika Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
This page was last updated on 8/4/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.